Press releases

A live webcast and replay of the March 3 session will be available.

“We plan to compete vigorously and successfully in the coronary stent market, and we have every intention of becoming, and remaining, the global leader in that market,” said Jim Tobin, President and Chief Executive Officer.

All pending disputes between the companies will be immediately dismissed; companies have also agreed to cross license patents in certain specified technology areas.

Cameron is developing a next-generation implantable cardioverter defibrillator (ICD) for the cardiac rhythm management market.

Represents a first-of-its-kind treatment option in Canada for carotid artery disease